IMCD N.V. (IMCD), a global leading distribution partner, and formulator of speciality chemicals and ingredients, announces its first nine months 2024 results. During the period, gross profit increase of 6% to €909 million (+8% on a constant currency basis). Operating EBITA increases by 1% to €403 million (+3% on a constant currency basis). Free cash flow of €299 million (first nine months of 2023: €364 million)

Valerie Diele-Braun, CEO: "I am pleased to report solid results for the first nine months of the year, despite the volatile global economic environment. On a forex adjusted basis, we delivered gross profit growth of 8% and an increase in operating EBITA of 3%. All segments contributed to our organic operating EBITA growth of 5% in the third quarter. Furthermore, we successfully expanded our global network and product portfolio by three acquisitions in EMEA and Latin America. We continue to look for opportunities to further strengthen our business through expansion of our product portfolio and by selective acquisitions, whilst remaining focused on optimising our commercial and operational excellence."